ERCC2 and skin cancer: In contrast, Yan et al. [21], Hu et al. [11], and Zhu et al. [112] suggested that the ERCC2 Asp312Asn polymorphism was not associated with breast cancer, head and neck cancer, and skin cancer, respectively.